Li Man, Xia Pengyan, Du Ying, Liu Shengwu, Huang Guanling, Chen Jun, Zhang Honglian, Hou Ning, Cheng Xuan, Zhou Luyu, Li Peifeng, Yang Xiao, Fan Zusen
From the CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, University of Chinese Academy of Sciences, Beijing 100049.
From the CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101.
J Biol Chem. 2014 Jun 20;289(25):17647-57. doi: 10.1074/jbc.M114.572420. Epub 2014 May 9.
Natural killer (NK) cell activation is well orchestrated by a wide array of NK cell receptor repertoire. T-cell immunoglobulin and ITIM domain (TIGIT) receptor was recently defined as an inhibitory receptor that is expressed on NK cells and T cells. TIGIT receptor/poliovirus receptor (PVR) ligand engagement signaling inhibits cytotoxicity mediated by NK and CD8(+) T cells. However, it is unclear how TIGIT/PVR signaling regulates cytokine secretion in NK cells. Here we show that TIGIT/PVR engagement suppresses interferon-γ (IFN-γ) production of NK cells. TIGIT transgenic NK cells generate less IFN-γ undergoing TIGIT/PVR ligation. Moreover, TIGIT knock-out NK cells produce much more IFN-γ. TIGIT/PVR ligation signaling mediates suppression of IFN-γ production via the NF-κB pathway. We identified a novel adaptor β-arrestin 2 that associates with phosphorylated TIGIT for further recruitment of SHIP1 (SH2-containing inositol phosphatase 1) through the ITT-like motif. Importantly, SHIP1, but not other phosphatases, impairs the TNF receptor-associated factor 6 (TRAF6) autoubiquitination to abolish NF-κB activation, leading to suppression of IFN-γ production in NK cells.
自然杀伤(NK)细胞的激活由多种NK细胞受体库精心调控。T细胞免疫球蛋白和ITIM结构域(TIGIT)受体最近被定义为一种在NK细胞和T细胞上表达的抑制性受体。TIGIT受体/脊髓灰质炎病毒受体(PVR)配体结合信号抑制NK细胞和CD8(+) T细胞介导的细胞毒性。然而,尚不清楚TIGIT/PVR信号如何调节NK细胞中的细胞因子分泌。在此我们表明,TIGIT/PVR结合会抑制NK细胞的干扰素-γ(IFN-γ)产生。TIGIT转基因NK细胞在经历TIGIT/PVR连接时产生的IFN-γ较少。此外,TIGIT基因敲除的NK细胞产生的IFN-γ要多得多。TIGIT/PVR连接信号通过NF-κB途径介导对IFN-γ产生的抑制。我们鉴定出一种新型衔接蛋白β-抑制蛋白2,它与磷酸化的TIGIT结合,通过类似ITT的基序进一步募集SHIP1(含SH2结构域的肌醇磷酸酶1)。重要的是,SHIP1而非其他磷酸酶会损害肿瘤坏死因子受体相关因子6(TRAF6)的自身泛素化,从而消除NF-κB激活,导致NK细胞中IFN-γ产生受到抑制。